Point72 Hong Kong’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Point72 Hong Kong’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,870	Closed	-$14K	–	2470
2021 Q1	$14K	Buy	2,870 +1,899	+196%	+$15.3K	﹤0.01%	1551
2020 Q4	$12K	Sell	971 -445	-31%	-$5.07K	﹤0.01%	1518
2020 Q3	$14K	Buy	1,416 +298	+27%	+$2.94K	﹤0.01%	945
2020 Q2	$11K	Buy	+1,118	New	+$10.7K	﹤0.01%	972
2019 Q3	–	Sell	-24	Closed	–	–	1446
2019 Q2	$0	Sell	24 -1,455	-98%	-$15.6K	﹤0.01%	1485
2019 Q1	$18K	Buy	+1,479	New	+$21.8K	0.01%	696
2017 Q4	–	Sell	-114	Closed	-$2K	–	1154
2017 Q3	$2K	Buy	+114	New	+$1.65K	﹤0.01%	666
2016 Q4	–	Sell	-100	Closed	-$1K	–	1088
2016 Q3	$1K	Buy	+100	New	+$1.09K	﹤0.01%	716

Other funds holding CNCE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Point72 Hong Kong's CNCE Position: Q2 2021 in Review

Point72 Hong Kong sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2021, closing a stake of 2,870 shares — an estimated $14K sold.

Point72 Hong Kong first reported a position in CNCE in Q3 2016 and held it in 8 quarters. The position peaked at $18K in Q1 2019. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2021.

Point72 Hong Kong reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Point72 Hong Kong sold 2,870 Concert Pharmaceuticals, Inc. shares in Q2 2021, an estimated $14K.
Point72 Hong Kong first reported a position in Concert Pharmaceuticals, Inc. in Q3 2016 and held it in 8 quarters.
Point72 Hong Kong's Concert Pharmaceuticals, Inc. position peaked at $18K in Q1 2019.
79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2021.

Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.